Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie Halene

Showing results (91-100 of 124) with videos related to

Pageof 13
Sort By:
Nature|April 28, 2022
Inflammasome activation in infected macrophages drives COVID-19 pathologyEsen Sefik, Rihao Qu, Caroline Junqueira, et al.
Science Immunology|August 9, 2024
The human CD47 checkpoint is targeted by an immunosuppressive <i>Aedes aegypti</i> salivary factor to enhance arboviral skin infectivityAlejandro Marin-Lopez, John D Huck, Allen T Esterly, et al.
Biorxiv : the Preprint Server for Biology|September 12, 2022
Microfluidic immuno-serology assay revealed a limited diversity of protection against COVID-19 in patients with altered immunityDongjoo Kim, Giulia Biancon, Zhiliang Bai, et al.
Nature Communications|January 22, 2019
A highly efficient and faithful MDS patient-derived xenotransplantation model for pre-clinical studiesYuanbin Song, Anthony Rongvaux, Ashley Taylor, et al.
Science (New York, N.Y.)|March 6, 2021
Combined liver-cytokine humanization comes to the rescue of circulating human red blood cellsYuanbin Song, Liang Shan, Rana Gbyli, et al.
Small Methods|June 14, 2023
Microfluidic Immuno-Serolomic Assay Reveals Systems Level Association with COVID-19 Pathology and Vaccine ProtectionDongjoo Kim, Giulia Biancon, Zhiliang Bai, et al.
Science Advances|March 26, 2025
An in vivo screen identifies NAT10 as a master regulator of brain metastasisJocelyn F Chen, Peng Xu, Wesley L Cai, et al.
Medrxiv : the Preprint Server for Health Sciences|February 8, 2022
A Phase 2 Randomized, Double-Blind, Placebo-controlled Trial of Oral Camostat Mesylate for Early Treatment of COVID-19 Outpatients Showed Shorter Illness Course and Attenuation of Loss of Smell and TasteGeoffrey Chupp, Anne Spichler-Moffarah, Ole S Søgaard, et al.
Molecular Cell|March 18, 2022
Precision analysis of mutant U2AF1 activity reveals deployment of stress granules in myeloid malignanciesGiulia Biancon, Poorval Joshi, Joshua T Zimmer, et al.
Immunity|June 5, 2020
m<sup>6</sup>A Modification Prevents Formation of Endogenous Double-Stranded RNAs and Deleterious Innate Immune Responses during Hematopoietic DevelopmentYimeng Gao, Radovan Vasic, Yuanbin Song, et al.
Pageof 13

Showing results (91-100 of 124) with videos related to

Sort By:
Pageof 13
Nature|April 28, 2022
Inflammasome activation in infected macrophages drives COVID-19 pathologyEsen Sefik, Rihao Qu, Caroline Junqueira, et al.
Science Immunology|August 9, 2024
The human CD47 checkpoint is targeted by an immunosuppressive <i>Aedes aegypti</i> salivary factor to enhance arboviral skin infectivityAlejandro Marin-Lopez, John D Huck, Allen T Esterly, et al.
Biorxiv : the Preprint Server for Biology|September 12, 2022
Microfluidic immuno-serology assay revealed a limited diversity of protection against COVID-19 in patients with altered immunityDongjoo Kim, Giulia Biancon, Zhiliang Bai, et al.
Nature Communications|January 22, 2019
A highly efficient and faithful MDS patient-derived xenotransplantation model for pre-clinical studiesYuanbin Song, Anthony Rongvaux, Ashley Taylor, et al.
Science (New York, N.Y.)|March 6, 2021
Combined liver-cytokine humanization comes to the rescue of circulating human red blood cellsYuanbin Song, Liang Shan, Rana Gbyli, et al.
Small Methods|June 14, 2023
Microfluidic Immuno-Serolomic Assay Reveals Systems Level Association with COVID-19 Pathology and Vaccine ProtectionDongjoo Kim, Giulia Biancon, Zhiliang Bai, et al.
Science Advances|March 26, 2025
An in vivo screen identifies NAT10 as a master regulator of brain metastasisJocelyn F Chen, Peng Xu, Wesley L Cai, et al.
Medrxiv : the Preprint Server for Health Sciences|February 8, 2022
A Phase 2 Randomized, Double-Blind, Placebo-controlled Trial of Oral Camostat Mesylate for Early Treatment of COVID-19 Outpatients Showed Shorter Illness Course and Attenuation of Loss of Smell and TasteGeoffrey Chupp, Anne Spichler-Moffarah, Ole S Søgaard, et al.
Molecular Cell|March 18, 2022
Precision analysis of mutant U2AF1 activity reveals deployment of stress granules in myeloid malignanciesGiulia Biancon, Poorval Joshi, Joshua T Zimmer, et al.
Immunity|June 5, 2020
m<sup>6</sup>A Modification Prevents Formation of Endogenous Double-Stranded RNAs and Deleterious Innate Immune Responses during Hematopoietic DevelopmentYimeng Gao, Radovan Vasic, Yuanbin Song, et al.
Pageof 13